Parkman Healthcare Partners LLC Ardelyx, Inc. Transaction History
Parkman Healthcare Partners LLC
- $687 Million
- Q4 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 177,794 shares of ARDX stock, worth $876,524. This represents 0.13% of its overall portfolio holdings.
Number of Shares
177,794
Previous 126,940
40.06%
Holding current value
$876,524
Previous $874,000
5.15%
% of portfolio
0.13%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding ARDX
# of Institutions
231Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$120 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$86.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$70.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$57.2 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$51 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $762M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...